Skip to main content
SpringerLink
Log in

The management of patients who require temporary reversal of vitamin K antagonists for surgery: a practical guide for clinicians

  • Internal Medicine
  • Review Article Cardiovascular Diseases
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

Abstract

The management of patients who require temporary interruption of vitamin K antagonists is a common clinical problem, affecting an estimated 400 000 patients per year in Europe and North America. Managing such patients is challenging because of the lack of randomized trials assessing different perioperative anticoagulation management strategies and inconsistent recommendations from consensus groups. Recent non-randomized trials have helped to estimate the risks for arterial thromboembolism and bleeding with bridging anticoagulation involving low-molecular-weight heparin. The objectives of this review are to describe bridging inticoagulation and how it may be used with a short-acting heparin, such as unfractionated heparin or low-molecular-weight heparin, to discuss preoperative patient management, focusing on risk stratification for thromboembolic events and interruption of vitamin K antagonist therapy, and to discuss postoperative patient management, focusing on surgeryrelated bleedings risk and the resumption of bridging anticoagulation and vitamin K antagonist therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. American Heart Association. Heart disease and stroke statistics update. 2001: Dallas, TX: American Heart Association, 2001.

    Google Scholar 

  2. Douketis JD. Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians.Thromb Res 2002; 108:3–13.

    Article  PubMed  Google Scholar 

  3. Spandorfer JM, Lynch S, Weitz HH, Fertel S, Merli GJ. Use of enoxaparin for the chronically anticoagulated patient before and after procedures.Am J Cardiol 1999; 84: 478–80.

    Article  PubMed  CAS  Google Scholar 

  4. Carrel TP, Klingenmann W, Mohacsi PJ, et al. Perioperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: an institutional review.J Heart Valve Dis 1999; 8: 392–8.

    PubMed  CAS  Google Scholar 

  5. Albers GW, Dalen JE, Laupacis A, Manning WJ, Petersen P, Singer DE. Antithrombotic therapy in atrial fibrillation.Chest 2001; 119 (Suppl): 194S-206S.

    Article  PubMed  CAS  Google Scholar 

  6. Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valves.N Engl J Med 1996; 335: 407–16.

    Article  PubMed  CAS  Google Scholar 

  7. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from the five randomized controlled trials.Arch Intern Med 1994; 154: 1449–57.

  8. Kaplan RC, Tirschwell DL, Longstreth WT Jr, et al. Vascular events, mortality, and preventive therapy following ischemic stroke in the elderly.Neurology 2005; 65: 835–42.

    Article  PubMed  CAS  Google Scholar 

  9. Martineli J, Jimenez A, Rabago G, Artiz V, Fraile J, Farre J. Mechanical cardiac valve thrombosis: is thrombectomy justified?Circulation 1991; 84 (Suppl): III70-III75.

    Google Scholar 

  10. McKenna R. Abnormal coagulation in the postoperative period contributing to excessive bleeding.Med Clin North Am 2001; 85: 1277–310.

    Article  PubMed  CAS  Google Scholar 

  11. Spandorfer J. The management of anticoagulation before and after procedures.Med Clin North Am 2001; 85: 1109–16.

    Article  PubMed  CAS  Google Scholar 

  12. Dunn AS, Turpie AG. Perioperative management of patients receiving oral anticoagulants: a systematic review.Arch Intern Med 2003; 163: 901–8.

    Article  PubMed  Google Scholar 

  13. Jaffer AK, Brotman DJ, Chukaumerije N. When patients on warfarin need surgery.Cleve Clin J Med 2003; 70: 973–84.

    Article  PubMed  Google Scholar 

  14. Spyropoulos AC, Jenkins P, Bornikova L A disease management protocol for outpatient perioperative bridge therapy with enoxapain in patients requiring temporary interruption of long-term oral anticoagulation.Pharmacotherapy 2004; 24: 649–58.

    Article  PubMed  Google Scholar 

  15. Heit JA. Perioperative management of the chronically anticoagulated patient.J Thromb Thrombolysis 2001; 12: 81–7.

    Article  PubMed  CAS  Google Scholar 

  16. Hewitt RL, Chun KL, Flint LM. Current clinical concepts in perioperative anticoagulation.Am Surg 1999; 65: 270–3.

    PubMed  CAS  Google Scholar 

  17. Spyropoulos AC, Turpie AG. Perioperative bridging interruption with heparin for the patient receiving longterm anticoagulation.Curr Opin Pulm Med 2005; 5: 373–80.

    Google Scholar 

  18. Jacobs LG, Nusbaum N. Perioperative management and reversal of antithrombotic therapy.Clin Ger Med 2001; 17: 189–201.

    Article  CAS  Google Scholar 

  19. Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery.N Engl J Med 1997; 336: 1506–11.

    Article  PubMed  CAS  Google Scholar 

  20. Shapira Y, Vaturi M, Sagie A. Anticoagulant management of patients with mechanical prosthetic valves undergoing noncardiac surgery: indications and unresolved issues.J Heart Valve Dis 2001; 10: 380–7.

    PubMed  CAS  Google Scholar 

  21. Bonow RO, Carabello B, de Leon AC, et al. ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Commitee on management of patients with valvular heart disease).J Am Coll Cardiol 1998; 32: 1558–65.

    Article  Google Scholar 

  22. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.Chest 2004; 126 (Suppl): 204S-233S.

    Article  PubMed  CAS  Google Scholar 

  23. Salem DN, Stein PD, Al-Ahmad A, et al. Antithrombotic therapy in valvular heart disease-native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.Chest 2004; 126 (Suppl): 457S-482S.

    Article  PubMed  CAS  Google Scholar 

  24. Douketis JD, Crowther MA, Cherian S, Kearon C. Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective non-cardiac surgery.Chest 1999; 116: 1240–6.

    Article  PubMed  CAS  Google Scholar 

  25. Douketis JD, Crowther MA, Cherian SS. Perioperative anticoagulation in patients with chronic atrial fibrillation undergoing elective surgery: results of a physician survey.Can J Cardiol 2000; 16: 326–30.

    PubMed  CAS  Google Scholar 

  26. Garcia DA, Ageno W, Libby EN, Bibb J, Douketis J, Crowther MA. Perioperative anticoagulation for patients with mechanical heart valves: a survey of current practice.J Thromb Thrombolysis 2004; 18: 199–203.

    Article  PubMed  Google Scholar 

  27. Ageno W, Garcia D, Libby E, Crowther MA. Managing oral anticoagulant therapy in patients with mechanical heart valves undergoing elective surgery: results of a survey conducted among Italian physicians.Blood Coagul Fibrinolysis 2004; 15: 623–8.

    Article  PubMed  Google Scholar 

  28. Hirsh J, Warkentin TE, Shaughnessy SG, et al. Heparin and low-molecular-weight heparin: mechanism of action, pharmacokinetics, dosing, monitoring, efficacy, and safety.Chest 2001; 119 (Suppl): 64S-94S.

    Article  PubMed  CAS  Google Scholar 

  29. Spyropoulos AC, Frost FJ, Hurley JS, Roberts M. Costs and clinical outcomes associated with low-molecular-weight heparin vs unfractionated heparin for perioperative bridging in patients receiving long-term oral anticoagulant therapy.Chest 2004; 125: 1642–50.

    Article  PubMed  Google Scholar 

  30. Douketis JD, Johnson JA, Turpie AG. Low-molecularweight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.Arch Intern Med 2004; 164: 1319–26.

    Article  PubMed  CAS  Google Scholar 

  31. Kovacs MJ, Kearon C, Rodger M, et al. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.Circulation 2004; 110: 1658–63.

    Article  PubMed  CAS  Google Scholar 

  32. Spyropoulos AS, Turpie AG, Dunn A, et al. for the REGIMEN Investigators. Registry of patients on chronic oral anticoagulant therapy requiring (low-molecularweight) heparin for an elective surgical procedure (REGIMEN): analysis of a large, long-term, multi-center study.Blood 2004; 104: 205A-206A.

    Google Scholar 

  33. Dunn AS, Spyropoulos AC, Sirko SP, Turpie AG. Perioperative bridging therapy with enoxaparin in patients requiring interruption of long-term oral anticoagulant therapy: a multicenter cohort study [abstract].Blood 2004; 104: 488A.

    Google Scholar 

  34. Turpie AG, Douketis JD. Enoxaparin is effective and safe as bridging anticoagulation in patients with a mechanical prosthetic heart valve who reqire temporary interruption of warfarin because of surgery or an invasive procedure [abstract].Blood 2004; 104: 202A.

    Google Scholar 

  35. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.JAMA 2001; 285: 2864–70.

    Article  PubMed  CAS  Google Scholar 

  36. Douketis JD, Foster GA, Crowther MA, Prins MH, Ginsberg JS. Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy.Arch Intern Med 2000; 160: 3431–6.

    Article  PubMed  CAS  Google Scholar 

  37. Kearon C, Gent M, Hirsh J, et al. A comparison of three months of anticoagulant therapy with extended anticoagulation for a first episode of idiopathic venous thromboembolism.N Engl J Med 1999; 340: 901–7.

    Article  PubMed  CAS  Google Scholar 

  38. Schulman S, Svenungsson E, Granqvist S, and the Duration of Anticoagulation Study Group. Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy.Am J Med 1998; 104: 332–8.

    Article  PubMed  CAS  Google Scholar 

  39. Palareti G, Legnani C. Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations.Clin Pharmacokinet 1996; 30: 300–13.

    Article  PubMed  CAS  Google Scholar 

  40. White RH, McKitrick T, Hutchison R, et al. Temporary discontinuation of warfarin therapy: changes in the international normalized ratio.Ann Intern Med 1995; 122: 40–2.

    PubMed  CAS  Google Scholar 

  41. Crowther MA, Julian J, Douketis J, et al. Low-dose oral vitamin K for the treatment of warfarin-associated coagulopathy.Lancet 2000; 356: 1551–3.

    Article  PubMed  CAS  Google Scholar 

  42. Crowther MA, Donovan D, Harrison L, McGinnis, Ginsberg J. Low-dose oral vitamin K reliably reverses overanticoagulation due to warfarin.Thromb Haemost 1998; 79: 1116–8.

    PubMed  CAS  Google Scholar 

  43. Crowther MA, Douketis JD, Schnurr T, et al. Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial.Ann Intern Med 2002; 137: 251–4.

    PubMed  CAS  Google Scholar 

  44. Burger W, Chemnitius JM, Kneissl GD, Rucker G. Low-dose aspirin for secondary cardiovascular prevention— cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation—review and meta-analysis.J Intern Med 2005; 257: 399–414.

    Article  PubMed  CAS  Google Scholar 

  45. Douketis JD, Woods K, Foster GA, Crowther MA. Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery.Thromb Haemost 2005; 94: 528–31.

    PubMed  CAS  Google Scholar 

  46. Nielson JD, Gram J, Holm-Nielsen A, et al. Post-operative blood loss after transurethral prostatectomy is dependent on in-situ fibrinolysis.Br J Urol 1997; 80: 889–93.

    Google Scholar 

  47. Lazio BE, Sumard JM. Anticoagulation in neurosurgical patients.Neurosurgery 1999; 45: 838–47.

    Article  PubMed  CAS  Google Scholar 

  48. Kuwada SK, Balm R, Gostout CJ. The risk of withdrawing chronic anticoagulation because of acute GI bleeding.Am J Gastroenterol 1996; 91: 1116–9.

    PubMed  CAS  Google Scholar 

  49. Yiu KH, Siu CW, Jim MH, et al. Comparison of the efficacy and safety profiles of intravenous vitamin K and fresh frozen plasma as treatment of warfarin-related overanticoagulation in patients with mechanical heart vales.Am J Cardiol 2006; 97: 409–11.

    Article  PubMed  CAS  Google Scholar 

  50. Lubetsky A, Yonath H, Olchovsky D, Loebstein R, Halkin H, Ezra D. Comparison of oral vs intravenous phytonadione (vitamin K) in patients with excessive anticoagulation: a prospective randomized controlled study.Arch Intern Med 2003; 163: 2469–73.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, McMaster University, Hamilton, Ontario, Canada

    Caterina Mannucci & James D. Douketis

  2. Department of Medicine, St. Joseph's Healthcare, Room F-544, 50 Charlton Ave. East, L8N 4A6, Hamilton, ON, Canada

    Caterina Mannucci & James D. Douketis

Authors
  1. Caterina Mannucci
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James D. Douketis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James D. Douketis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mannucci, C., Douketis, J.D. The management of patients who require temporary reversal of vitamin K antagonists for surgery: a practical guide for clinicians. Int Emergency Med 1, 96–104 (2006). https://doi.org/10.1007/BF02936533

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02936533

Key words

Search

Navigation